カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のアレルギーワクチン市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Allergy Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19112）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19112
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：93
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のアレルギーワクチン市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

アレルギーワクチン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のアレルギーワクチンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

アレルギーワクチン市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・皮下免疫療法、舌下免疫療法

用途別セグメントは次のように区分されます。
・アレルギー性鼻炎、アレルギー性喘息、その他

世界のアレルギーワクチン市場の主要な市場プレーヤーは以下のとおりです。
・ALK-Abello、Stallergenes Greer、Merck、Allergy Therapeutics、WOLW Pharma、HAL、Holister Stier、Leti

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、アレルギーワクチン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なアレルギーワクチンメーカーの企業概要、2019年～2022年までのアレルギーワクチンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なアレルギーワクチンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別アレルギーワクチンの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのアレルギーワクチンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのアレルギーワクチン市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびアレルギーワクチンの産業チェーンを掲載しています。
・第13、14、15章では、アレルギーワクチンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- アレルギーワクチンの概要
- 種類別分析（2017年vs2021年vs2028年）：皮下免疫療法、舌下免疫療法
- 用途別分析（2017年vs2021年vs2028年）：アレルギー性鼻炎、アレルギー性喘息、その他
- 世界のアレルギーワクチン市場規模・予測
- 世界のアレルギーワクチン生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- ALK-Abello、Stallergenes Greer、Merck、Allergy Therapeutics、WOLW Pharma、HAL、Holister Stier、Leti
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：皮下免疫療法、舌下免疫療法
・用途別分析2017年-2028年：アレルギー性鼻炎、アレルギー性喘息、その他
・アレルギーワクチンの北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・アレルギーワクチンのヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・アレルギーワクチンのアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・アレルギーワクチンの南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・アレルギーワクチンの中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Allergy Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Allergy Vaccine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Allergic Rhinitis accounting for % of the Allergy Vaccine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Subcutaneous Immunotherapy segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Allergy Vaccine include ALK-Abello, Stallergenes Greer, Merck, Allergy Therapeutics, and WOLW Pharma, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Allergy Vaccine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Subcutaneous Immunotherapy
Sublingual Immunotherapy
Market segment by Application can be divided into
Allergic Rhinitis
Allergic Asthma
Other
The key market players for global Allergy Vaccine market are listed below:
ALK-Abello
Stallergenes Greer
Merck
Allergy Therapeutics
WOLW Pharma
HAL
Holister Stier
Leti
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Allergy Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Allergy Vaccine, with price, sales, revenue and global market share of Allergy Vaccine from 2019 to 2022.
Chapter 3, the Allergy Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Allergy Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Allergy Vaccine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Allergy Vaccine.
Chapter 13, 14, and 15, to describe Allergy Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Allergy Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Allergy Vaccine Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Subcutaneous Immunotherapy
1.2.3 Sublingual Immunotherapy
1.3 Market Analysis by Application
1.3.1 Overview: Global Allergy Vaccine Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Allergic Rhinitis
1.3.3 Allergic Asthma
1.3.4 Other
1.4 Global Allergy Vaccine Market Size & Forecast
1.4.1 Global Allergy Vaccine Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Allergy Vaccine Sales in Volume (2017-2028)
1.4.3 Global Allergy Vaccine Price (2017-2028)
1.5 Global Allergy Vaccine Production Capacity Analysis
1.5.1 Global Allergy Vaccine Total Production Capacity (2017-2028)
1.5.2 Global Allergy Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Allergy Vaccine Market Drivers
1.6.2 Allergy Vaccine Market Restraints
1.6.3 Allergy Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 ALK-Abello
2.1.1 ALK-Abello Details
2.1.2 ALK-Abello Major Business
2.1.3 ALK-Abello Allergy Vaccine Product and Services
2.1.4 ALK-Abello Allergy Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Stallergenes Greer
2.2.1 Stallergenes Greer Details
2.2.2 Stallergenes Greer Major Business
2.2.3 Stallergenes Greer Allergy Vaccine Product and Services
2.2.4 Stallergenes Greer Allergy Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Allergy Vaccine Product and Services
2.3.4 Merck Allergy Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Allergy Therapeutics
2.4.1 Allergy Therapeutics Details
2.4.2 Allergy Therapeutics Major Business
2.4.3 Allergy Therapeutics Allergy Vaccine Product and Services
2.4.4 Allergy Therapeutics Allergy Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 WOLW Pharma
2.5.1 WOLW Pharma Details
2.5.2 WOLW Pharma Major Business
2.5.3 WOLW Pharma Allergy Vaccine Product and Services
2.5.4 WOLW Pharma Allergy Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 HAL
2.6.1 HAL Details
2.6.2 HAL Major Business
2.6.3 HAL Allergy Vaccine Product and Services
2.6.4 HAL Allergy Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Holister Stier
2.7.1 Holister Stier Details
2.7.2 Holister Stier Major Business
2.7.3 Holister Stier Allergy Vaccine Product and Services
2.7.4 Holister Stier Allergy Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Leti
2.8.1 Leti Details
2.8.2 Leti Major Business
2.8.3 Leti Allergy Vaccine Product and Services
2.8.4 Leti Allergy Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Allergy Vaccine Breakdown Data by Manufacturer
3.1 Global Allergy Vaccine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Allergy Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Allergy Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 Allergy Vaccine Manufacturer Market Share in 2021
3.4.2 Top 6 Allergy Vaccine Manufacturer Market Share in 2021
3.5 Global Allergy Vaccine Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Allergy Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Allergy Vaccine Market Size by Region
4.1.1 Global Allergy Vaccine Sales in Volume by Region (2017-2028)
4.1.2 Global Allergy Vaccine Revenue by Region (2017-2028)
4.2 North America Allergy Vaccine Revenue (2017-2028)
4.3 Europe Allergy Vaccine Revenue (2017-2028)
4.4 Asia-Pacific Allergy Vaccine Revenue (2017-2028)
4.5 South America Allergy Vaccine Revenue (2017-2028)
4.6 Middle East and Africa Allergy Vaccine Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Allergy Vaccine Sales in Volume by Type (2017-2028)
5.2 Global Allergy Vaccine Revenue by Type (2017-2028)
5.3 Global Allergy Vaccine Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Allergy Vaccine Sales in Volume by Application (2017-2028)
6.2 Global Allergy Vaccine Revenue by Application (2017-2028)
6.3 Global Allergy Vaccine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Allergy Vaccine Sales by Type (2017-2028)
7.2 North America Allergy Vaccine Sales by Application (2017-2028)
7.3 North America Allergy Vaccine Market Size by Country
7.3.1 North America Allergy Vaccine Sales in Volume by Country (2017-2028)
7.3.2 North America Allergy Vaccine Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Allergy Vaccine Sales by Type (2017-2028)
8.2 Europe Allergy Vaccine Sales by Application (2017-2028)
8.3 Europe Allergy Vaccine Market Size by Country
8.3.1 Europe Allergy Vaccine Sales in Volume by Country (2017-2028)
8.3.2 Europe Allergy Vaccine Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Allergy Vaccine Sales by Type (2017-2028)
9.2 Asia-Pacific Allergy Vaccine Sales by Application (2017-2028)
9.3 Asia-Pacific Allergy Vaccine Market Size by Region
9.3.1 Asia-Pacific Allergy Vaccine Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Allergy Vaccine Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Allergy Vaccine Sales by Type (2017-2028)
10.2 South America Allergy Vaccine Sales by Application (2017-2028)
10.3 South America Allergy Vaccine Market Size by Country
10.3.1 South America Allergy Vaccine Sales in Volume by Country (2017-2028)
10.3.2 South America Allergy Vaccine Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Allergy Vaccine Sales by Type (2017-2028)
11.2 Middle East & Africa Allergy Vaccine Sales by Application (2017-2028)
11.3 Middle East & Africa Allergy Vaccine Market Size by Country
11.3.1 Middle East & Africa Allergy Vaccine Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Allergy Vaccine Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Allergy Vaccine and Key Manufacturers
12.2 Manufacturing Costs Percentage of Allergy Vaccine
12.3 Allergy Vaccine Production Process
12.4 Allergy Vaccine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Allergy Vaccine Typical Distributors
13.3 Allergy Vaccine Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Allergy Vaccine Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Allergy Vaccine Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. ALK-Abello Basic Information, Manufacturing Base and Competitors
Table 4. ALK-Abello Major Business
Table 5. ALK-Abello Allergy Vaccine Product and Services
Table 6. ALK-Abello Allergy Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Stallergenes Greer Basic Information, Manufacturing Base and Competitors
Table 8. Stallergenes Greer Major Business
Table 9. Stallergenes Greer Allergy Vaccine Product and Services
Table 10. Stallergenes Greer Allergy Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Merck Basic Information, Manufacturing Base and Competitors
Table 12. Merck Major Business
Table 13. Merck Allergy Vaccine Product and Services
Table 14. Merck Allergy Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Allergy Therapeutics Basic Information, Manufacturing Base and Competitors
Table 16. Allergy Therapeutics Major Business
Table 17. Allergy Therapeutics Allergy Vaccine Product and Services
Table 18. Allergy Therapeutics Allergy Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. WOLW Pharma Basic Information, Manufacturing Base and Competitors
Table 20. WOLW Pharma Major Business
Table 21. WOLW Pharma Allergy Vaccine Product and Services
Table 22. WOLW Pharma Allergy Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. HAL Basic Information, Manufacturing Base and Competitors
Table 24. HAL Major Business
Table 25. HAL Allergy Vaccine Product and Services
Table 26. HAL Allergy Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Holister Stier Basic Information, Manufacturing Base and Competitors
Table 28. Holister Stier Major Business
Table 29. Holister Stier Allergy Vaccine Product and Services
Table 30. Holister Stier Allergy Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Leti Basic Information, Manufacturing Base and Competitors
Table 32. Leti Major Business
Table 33. Leti Allergy Vaccine Product and Services
Table 34. Leti Allergy Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Global Allergy Vaccine Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 36. Global Allergy Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 37. Market Position of Manufacturers in Allergy Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 38. Global Allergy Vaccine Production Capacity by Company, (K Units): 2020 VS 2021
Table 39. Head Office and Allergy Vaccine Production Site of Key Manufacturer
Table 40. Allergy Vaccine New Entrant and Capacity Expansion Plans
Table 41. Allergy Vaccine Mergers & Acquisitions in the Past Five Years
Table 42. Global Allergy Vaccine Sales by Region (2017-2022) & (K Units)
Table 43. Global Allergy Vaccine Sales by Region (2023-2028) & (K Units)
Table 44. Global Allergy Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 45. Global Allergy Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 46. Global Allergy Vaccine Sales by Type (2017-2022) & (K Units)
Table 47. Global Allergy Vaccine Sales by Type (2023-2028) & (K Units)
Table 48. Global Allergy Vaccine Revenue by Type (2017-2022) & (USD Million)
Table 49. Global Allergy Vaccine Revenue by Type (2023-2028) & (USD Million)
Table 50. Global Allergy Vaccine Price by Type (2017-2022) & (US$/Unit)
Table 51. Global Allergy Vaccine Price by Type (2023-2028) & (US$/Unit)
Table 52. Global Allergy Vaccine Sales by Application (2017-2022) & (K Units)
Table 53. Global Allergy Vaccine Sales by Application (2023-2028) & (K Units)
Table 54. Global Allergy Vaccine Revenue by Application (2017-2022) & (USD Million)
Table 55. Global Allergy Vaccine Revenue by Application (2023-2028) & (USD Million)
Table 56. Global Allergy Vaccine Price by Application (2017-2022) & (US$/Unit)
Table 57. Global Allergy Vaccine Price by Application (2023-2028) & (US$/Unit)
Table 58. North America Allergy Vaccine Sales by Country (2017-2022) & (K Units)
Table 59. North America Allergy Vaccine Sales by Country (2023-2028) & (K Units)
Table 60. North America Allergy Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 61. North America Allergy Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 62. North America Allergy Vaccine Sales by Type (2017-2022) & (K Units)
Table 63. North America Allergy Vaccine Sales by Type (2023-2028) & (K Units)
Table 64. North America Allergy Vaccine Sales by Application (2017-2022) & (K Units)
Table 65. North America Allergy Vaccine Sales by Application (2023-2028) & (K Units)
Table 66. Europe Allergy Vaccine Sales by Country (2017-2022) & (K Units)
Table 67. Europe Allergy Vaccine Sales by Country (2023-2028) & (K Units)
Table 68. Europe Allergy Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 69. Europe Allergy Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 70. Europe Allergy Vaccine Sales by Type (2017-2022) & (K Units)
Table 71. Europe Allergy Vaccine Sales by Type (2023-2028) & (K Units)
Table 72. Europe Allergy Vaccine Sales by Application (2017-2022) & (K Units)
Table 73. Europe Allergy Vaccine Sales by Application (2023-2028) & (K Units)
Table 74. Asia-Pacific Allergy Vaccine Sales by Region (2017-2022) & (K Units)
Table 75. Asia-Pacific Allergy Vaccine Sales by Region (2023-2028) & (K Units)
Table 76. Asia-Pacific Allergy Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 77. Asia-Pacific Allergy Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 78. Asia-Pacific Allergy Vaccine Sales by Type (2017-2022) & (K Units)
Table 79. Asia-Pacific Allergy Vaccine Sales by Type (2023-2028) & (K Units)
Table 80. Asia-Pacific Allergy Vaccine Sales by Application (2017-2022) & (K Units)
Table 81. Asia-Pacific Allergy Vaccine Sales by Application (2023-2028) & (K Units)
Table 82. South America Allergy Vaccine Sales by Country (2017-2022) & (K Units)
Table 83. South America Allergy Vaccine Sales by Country (2023-2028) & (K Units)
Table 84. South America Allergy Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 85. South America Allergy Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 86. South America Allergy Vaccine Sales by Type (2017-2022) & (K Units)
Table 87. South America Allergy Vaccine Sales by Type (2023-2028) & (K Units)
Table 88. South America Allergy Vaccine Sales by Application (2017-2022) & (K Units)
Table 89. South America Allergy Vaccine Sales by Application (2023-2028) & (K Units)
Table 90. Middle East & Africa Allergy Vaccine Sales by Region (2017-2022) & (K Units)
Table 91. Middle East & Africa Allergy Vaccine Sales by Region (2023-2028) & (K Units)
Table 92. Middle East & Africa Allergy Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 93. Middle East & Africa Allergy Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 94. Middle East & Africa Allergy Vaccine Sales by Type (2017-2022) & (K Units)
Table 95. Middle East & Africa Allergy Vaccine Sales by Type (2023-2028) & (K Units)
Table 96. Middle East & Africa Allergy Vaccine Sales by Application (2017-2022) & (K Units)
Table 97. Middle East & Africa Allergy Vaccine Sales by Application (2023-2028) & (K Units)
Table 98. Allergy Vaccine Raw Material
Table 99. Key Manufacturers of Allergy Vaccine Raw Materials
Table 100. Direct Channel Pros & Cons
Table 101. Indirect Channel Pros & Cons
Table 102. Allergy Vaccine Typical Distributors
Table 103. Allergy Vaccine Typical Customers
List of Figures
Figure 1. Allergy Vaccine Picture
Figure 2. Global Allergy Vaccine Revenue Market Share by Type in 2021
Figure 3. Subcutaneous Immunotherapy
Figure 4. Sublingual Immunotherapy
Figure 5. Global Allergy Vaccine Revenue Market Share by Application in 2021
Figure 6. Allergic Rhinitis
Figure 7. Allergic Asthma
Figure 8. Other
Figure 9. Global Allergy Vaccine Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global Allergy Vaccine Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Allergy Vaccine Sales (2017-2028) & (K Units)
Figure 12. Global Allergy Vaccine Price (2017-2028) & (US$/Unit)
Figure 13. Global Allergy Vaccine Production Capacity (2017-2028) & (K Units)
Figure 14. Global Allergy Vaccine Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Allergy Vaccine Market Drivers
Figure 16. Allergy Vaccine Market Restraints
Figure 17. Allergy Vaccine Market Trends
Figure 18. Global Allergy Vaccine Sales Market Share by Manufacturer in 2021
Figure 19. Global Allergy Vaccine Revenue Market Share by Manufacturer in 2021
Figure 20. Allergy Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Allergy Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Allergy Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Allergy Vaccine Sales Market Share by Region (2017-2028)
Figure 24. Global Allergy Vaccine Revenue Market Share by Region (2017-2028)
Figure 25. North America Allergy Vaccine Revenue (2017-2028) & (USD Million)
Figure 26. Europe Allergy Vaccine Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Allergy Vaccine Revenue (2017-2028) & (USD Million)
Figure 28. South America Allergy Vaccine Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Allergy Vaccine Revenue (2017-2028) & (USD Million)
Figure 30. Global Allergy Vaccine Sales Market Share by Type (2017-2028)
Figure 31. Global Allergy Vaccine Revenue Market Share by Type (2017-2028)
Figure 32. Global Allergy Vaccine Price by Type (2017-2028) & (US$/Unit)
Figure 33. Global Allergy Vaccine Sales Market Share by Application (2017-2028)
Figure 34. Global Allergy Vaccine Revenue Market Share by Application (2017-2028)
Figure 35. Global Allergy Vaccine Price by Application (2017-2028) & (US$/Unit)
Figure 36. North America Allergy Vaccine Sales Market Share by Type (2017-2028)
Figure 37. North America Allergy Vaccine Sales Market Share by Application (2017-2028)
Figure 38. North America Allergy Vaccine Sales Market Share by Country (2017-2028)
Figure 39. North America Allergy Vaccine Revenue Market Share by Country (2017-2028)
Figure 40. United States Allergy Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Allergy Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Allergy Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Allergy Vaccine Sales Market Share by Type (2017-2028)
Figure 44. Europe Allergy Vaccine Sales Market Share by Application (2017-2028)
Figure 45. Europe Allergy Vaccine Sales Market Share by Country (2017-2028)
Figure 46. Europe Allergy Vaccine Revenue Market Share by Country (2017-2028)
Figure 47. Germany Allergy Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Allergy Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Allergy Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Allergy Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Allergy Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Allergy Vaccine Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Allergy Vaccine Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Allergy Vaccine Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Allergy Vaccine Revenue Market Share by Region (2017-2028)
Figure 56. China Allergy Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Allergy Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Allergy Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Allergy Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Allergy Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Allergy Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Allergy Vaccine Sales Market Share by Type (2017-2028)
Figure 63. South America Allergy Vaccine Sales Market Share by Application (2017-2028)
Figure 64. South America Allergy Vaccine Sales Market Share by Country (2017-2028)
Figure 65. South America Allergy Vaccine Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Allergy Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Allergy Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Allergy Vaccine Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Allergy Vaccine Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Allergy Vaccine Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Allergy Vaccine Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Allergy Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Allergy Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Allergy Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Allergy Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Allergy Vaccine in 2021
Figure 77. Manufacturing Process Analysis of Allergy Vaccine
Figure 78. Allergy Vaccine Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の猫アレルギー治療薬市場2022年：市場規模予測（～2028年）
  • 世界の獣毛アレルギー市場2022年：市場規模予測（～2028年）
  • 世界のアレルギー検査キット市場2022年：市場規模予測（～2028年）
  • 猫アレルギー治療薬のグローバル市場展望 2023年-2029年：抗ヒスタミン薬、副腎皮質ステロイド点鼻薬、鼻詰まり改善薬、ロイコトリエン拮抗薬、その他
  • 世界のアレルギー迅速検査市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19112 )"世界のアレルギーワクチン市場2022年：市場規模予測（～2028年）" (英文：Global Allergy Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。